Capital Analysts LLC’s iShares Biotechnology ETF IBB Stock Holding History

Capital Analysts LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1K	Sell	9 -11	-55%	-$1.22K	﹤0.01%	1352
2025 Q1	$3K	Hold	20	–	–	﹤0.01%	1286
2024 Q4	$3K	Buy	20 +9	+82%	+$1.35K	﹤0.01%	1199
2024 Q3	$2K	Buy	+11	New	+$2K	﹤0.01%	1218
2024 Q1	–	Sell	-134	Closed	-$18K	–	1126
2023 Q4	$18K	Sell	134 -46	-26%	-$6.18K	﹤0.01%	823
2023 Q3	$22K	Buy	180 +46	+34%	+$5.62K	﹤0.01%	752
2023 Q2	$17K	Hold	134	–	–	﹤0.01%	747
2023 Q1	$17K	Hold	134	–	–	﹤0.01%	751
2022 Q4	$18K	Hold	134	–	–	﹤0.01%	780
2022 Q3	$16K	Hold	134	–	–	﹤0.01%	740
2022 Q2	$16K	Sell	134 -18,432	-99%	-$2.2M	﹤0.01%	729
2022 Q1	$2.42M	Sell	18,566 -2,327	-11%	-$303K	0.15%	130
2021 Q4	$3.19M	Sell	20,893 -9,494	-31%	-$1.45M	0.19%	107
2021 Q3	$4.91M	Sell	30,387 -1,878	-6%	-$304K	0.32%	63
2021 Q2	$5.28M	Sell	32,265 -12,395	-28%	-$2.03M	0.35%	60
2021 Q1	$6.72M	Buy	44,660 +44,651	+496,122%	+$6.72M	0.46%	38
2020 Q4	$1K	Sell	9 -960	-99%	-$107K	﹤0.01%	721
2020 Q3	$131K	Sell	969 -1,515	-61%	-$205K	0.01%	283
2020 Q2	$340K	Buy	2,484 +1,485	+149%	+$203K	0.04%	197
2020 Q1	$108K	Sell	999 -17	-2%	-$1.84K	0.01%	250
2019 Q4	$122K	Buy	1,016 +29	+3%	+$3.48K	0.01%	276
2019 Q3	$98K	Buy	987 +71	+8%	+$7.05K	0.01%	283
2019 Q2	$100K	Hold	916	–	–	0.01%	273
2019 Q1	$102K	Hold	916	–	–	0.01%	262
2018 Q4	$88K	Hold	916	–	–	0.01%	253
2018 Q3	$112K	Buy	916 +16	+2%	+$1.96K	0.01%	238
2018 Q2	$99K	Sell	900 -5	-0.6%	-$550	0.01%	249
2018 Q1	$97K	Sell	905 -2,020	-69%	-$217K	0.01%	247
2017 Q4	$312K	Hold	2,925	–	–	0.04%	174
2017 Q3	$325K	Buy	2,925 +375	+15%	+$41.7K	0.04%	168
2017 Q2	$264K	Hold	2,550	–	–	0.04%	176
2017 Q1	$249K	Buy	+2,550	New	+$249K	0.04%	164
2016 Q4	–	Sell	-1,905	Closed	-$184K	–	367
2016 Q3	$184K	Buy	+1,905	New	+$184K	0.03%	174
2016 Q2	–	Sell	-1,050	Closed	-$91.3K	–	356
2016 Q1	$91.3K	Sell	1,050 -2,475	-70%	-$215K	0.02%	219
2015 Q4	$398K	Buy	+3,525	New	+$398K	0.08%	152